The first indication that mitochondrial HSP90 is involved in cancer metabolism came from a study in 2012 reporting that this chaperone maintained metabolic homeostasis in neoplastic cells by inhibiting nutrient-sensing AMP kinase (AMPK), autophagy, and the unfolded protein response [87]. Here, HSP90AB1 is linked to cancer.